Battlefield bioforensics

01Overview and value chain#

Markers EC: US Department of War forensic identification standards + UK National Security Strategy biosecurity programs | OECD: Bioeconomy policy & governance | Regulator: FDA (USA), EPA (USA)

Battlefield bioforensics applies forensic DNA and biological-detection science to military-specific problems: identifying unknown military remains through extended kinship inference, sequencing pathogens in the field rather than shipping samples to a distant laboratory, and preserving biological samples at ambient temperature so evidence collected far from a cold chain remains usable. A forensic kinship-inference platform compares a recovered sample’s SNP panel against relatives’ reference DNA to identify military unknowns years or decades after recovery, while a field-deployable sequencing program brings lab-grade pathogen detection to front-line units instead of requiring samples to travel back through a logistics chain. The category is distinct from civilian biodefense medical-countermeasure manufacturing and from commercial DNA-synthesis biosecurity screening covered elsewhere on this platform: battlefield bioforensics is specifically the applied forensic-science and field-diagnostic capability that identifies remains, detects pathogens and preserves biological evidence under military field conditions.

The key directions of battlefield bioforensics are:

Forensic DNA kinship identification: SNP-panel-based forensic platforms compare recovered biological samples against relatives’ reference DNA using extended kinship inference to identify military unknowns.
Field-deployable pathogen sequencing: sequencing programs bring lab-grade pathogen-detection capability directly to front-line units, delivering “assays on demand” rather than requiring samples to be shipped to a distant laboratory.
Ambient-temperature sample preservation: preservation chemistry keeps DNA and RNA samples viable for shipping and storage without a cold chain, solving the logistics problem of collecting biological evidence far from laboratory infrastructure.
Biosecurity forensic capability development: national laboratories develop integrated “One Health” microbial forensics capability spanning human, animal and environmental biological evidence for national biosecurity response.

Sectoral value chain#

[Field sample collection] ──> [Ambient-temperature preservation] ──> [Transport / field sequencing]
                                                                              │
                                                                    (kinship or pathogen match)
                                                                              │
                                                                              ▼
[Forensic identification / threat report] <─── [Analysis & confirmation] <─── [Database comparison]

Fig. 1— Sectoral value chain

Value chain levels#

Level	Description	Key inputs/outputs
Field sample collection	Biological samples (remains, pathogen material) are collected under field conditions, often far from laboratory infrastructure.	In: field site, collection kit. Out: raw biological sample.
Ambient-temperature preservation	Preservation chemistry stabilizes the sample for shipping and storage without requiring a cold chain.	In: raw biological sample, preservation reagent. Out: stabilized, shippable sample.
Transport or field sequencing	The sample is either shipped to a laboratory or sequenced directly at or near the collection site using field-deployable equipment.	In: stabilized sample. Out: raw sequencing/genetic data.
Database comparison	Generated data is compared against a reference database — kinship DNA for identification, pathogen-of-concern databases for threat detection.	In: raw genetic data, reference database. Out: match/no-match result.
Analysis and confirmation	Forensic analysts confirm the match through extended kinship inference or pathogen-confirmation protocols.	In: match result, case context. Out: confirmed identification or threat finding.
Forensic identification or threat report	The confirmed result is documented and reported to the requesting military or national-security authority.	In: confirmed finding. Out: forensic identification record or biological-threat report.

Table 1— Value chain levels

Cross-cutting technologies of the sector:

Extended kinship SNP inference: forensic panels compare a recovered sample against distant relatives’ reference DNA, extending identification capability beyond direct parent-child or sibling matches.
Ambient-temperature nucleic-acid preservation: stabilization chemistry keeps DNA and RNA samples viable during shipping and storage without refrigeration, solving a core logistics constraint of field forensic and diagnostic work.
One Health integrated forensic capability: microbial forensics programs span human, animal and environmental biological evidence, recognizing that a biosecurity incident often crosses these traditional category boundaries.

02US#

The US hosts a forensic DNA kinship-identification specialist, a national-security- contracted biological research institute, and a field-forensics sample-preservation company.

forensic kinship identification, CBRN-contracted pathogen detection, field sample preservation#

Signature Science: provides forensic validation of SNP panels for extended kinship inference used to identify US military unknowns, participating in forensic genealogy training and conferences.
MRIGlobal: holds a CDC contract for pathogen detection and develops custom pathogen-detection panels under national-security and CBRN defense-innovation positioning, with a program bringing lab-grade pathogen sequencing to front-line units.
GenTegra: publishes on field-based DNA sequencing that delivers “assays on demand” to the battlefield, alongside ambient-shipping DNA/RNA preservation products addressing the field-logistics constraint directly.

03CN#

No China-headquartered battlefield-bioforensics organization cleared this screening round with confirmed, on-domain evidence.

screening limitation#

Screening note: one candidate China-based military bioforensics institution was probed and did not return confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed; military forensic-science capability is inherently less publicly documented than civilian forensic services across all regions.

04EU#

The United Kingdom hosts a national defense science laboratory developing integrated microbial forensics capability for national biosecurity.

national microbial forensics capability development#

Dstl (United Kingdom): the Defence Science and Technology Laboratory has developed a new “One Health” microbial forensics capability for the UK, supporting the 2023 UK Biological Security Strategy and 2025 National Security Strategy, and solicits innovative proposals through its Biosecurity Frontiers program.

05Leading companies and research institutes#

Company / Institute	Country	Key products / platforms	Tech features	Status 2026
Signature Science	🇺🇸 USA	Forensic SNP-panel kinship identification	Extended kinship inference for military unknowns	Commercial
MRIGlobal	🇺🇸 USA	Custom pathogen-detection panels, front-line sequencing program	CDC contract, CBRN defense-innovation positioning	Research institute
GenTegra	🇺🇸 USA	Field-based DNA sequencing, ambient-shipping preservation	“Assays on demand” to the battlefield	Commercial
Dstl	🇬🇧 UK	One Health microbial forensics capability	National biosecurity strategy-aligned forensic program	Government program

Table 2— Leading companies and research institutes

06Tech stack and innovations#

The stack layers forensic identification science, field-deployable sequencing hardware and preservation chemistry on a common battlefield-bioforensics backbone.

Extended kinship-inference forensic identification:
- Forensic SNP panels are validated for extended kinship inference, comparing recovered samples against distant relatives’ reference DNA to identify military unknowns beyond the reach of direct-match forensic genealogy.
- This capability extends identification to cases where no direct familial DNA reference is available, a common constraint in historical or contested-remains cases.
Field-deployable pathogen sequencing:
- Sequencing programs deliver lab-grade pathogen-detection capability directly to front-line units, eliminating the logistics delay of shipping samples to a distant laboratory.
- This capability supports both battlefield medical decision-making and biological- threat detection in a single field-deployable platform.
Ambient-temperature preservation chemistry:
- Stabilization reagents keep DNA and RNA viable during shipping and storage without a cold chain, solving a core constraint of collecting biological evidence in field conditions far from laboratory infrastructure.
- This preservation capability underlies both the forensic identification and field-sequencing workflows, letting samples collected in the field remain usable however long transport takes.

07Value chains and production pipelines#

Industrial pipeline of battlefield bioforensic identification (US Department of War forensic standards / UK National Security Strategy)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Field sample            │ ───> │ 2. Ambient-temperature      │
│    collection               │      │    preservation             │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Database comparison     │ <─── │ 3. Transport or field       │
│                             │      │    sequencing               │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Analysis & confirmation │ ───> │ 6. Forensic identification  │
│                             │      │    or threat report         │
└───────────────────────────┘      └───────────────────────────┘

Fig. 2— Industrial pipeline of battlefield bioforensic identification (US Department of War forensic standards / UK National Security Strategy)

Stage 1: Field sample collection

Biological samples are collected under field conditions, often far from laboratory infrastructure.

Stage 2: Ambient-temperature preservation

Preservation chemistry stabilizes the sample for shipping and storage without requiring a cold chain.

Stage 3: Transport or field sequencing

The sample is either shipped to a laboratory or sequenced directly at or near the collection site.

Stage 4: Database comparison

Generated data is compared against a reference database.

Stage 5: Analysis and confirmation

Forensic analysts confirm the match through extended kinship inference or pathogen-confirmation protocols.

Stage 6: Forensic identification or threat report

The confirmed result is documented and reported to the requesting authority.

Supplier	Price	Lead time	Certificates	Risk	Confidence
Signature Science	custom	on request	Commercial	Medium	HIGH
MRIGlobal	custom	on request	Research institute	Medium	HIGH
GenTegra	custom	on request	Commercial	Medium	MEDIUM
Dstl	custom	on request	Government program	Medium	HIGH

AI Recommendation

Signature Science is the safest default if the specific need is forensic kinship-identification validation for recovering military unknowns — its SNP-panel validation work and forensic-genealogy training focus are directly on that problem. MRIGlobal is worth specifying if the broader need is pathogen-detection capability under national-security/CBRN contracting rather than identification specifically. GenTegra is the pick for the sample-preservation and field-sequencing logistics problem itself — solving how a sample collected far from a lab stays usable rather than the downstream forensic analysis. Dstl isn’t a vendor to contract directly in the commercial sense; it is the UK government’s own biosecurity forensic capability, useful as a reference point for national-level program design rather than a supplier relationship.

Key directions: forensic DNA kinship identification, field-deployable pathogen sequencing, ambient-temperature sample preservation, and biosecurity forensic capability development.

Regulatory: battlefield bioforensics work follows US Department of War forensic identification standards and, in the UK, sits within the National Security Strategy’s biosecurity programs rather than a civilian forensic-science regulatory regime.

Companies not in table: Fraunhofer was dropped as a candidate — its confirming evidence was actually about audio and deepfake forensics, an unrelated Fraunhofer institute’s work, not bioforensics. Applied DNA Sciences was also dropped — its confirmed defense contract was for anti-counterfeiting DNA tagging, not battlefield bioforensic identification, a scope mismatch rather than genuine evidence for this category. One China-based candidate was checked but did not return confirming evidence.